Outpatient Surgery Magazine

Creative Ways to Save Money in the OR - May 2016 - Subscribe to Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://outpatientsurgery.uberflip.com/i/675921

Contents of this Issue

Navigation

Page 125 of 154

inguinal hernia cases. "When you place the mesh in this area, the con- cern is that it's going to slide around and expose the gap, which would cause recurrence," he says. "The most obvious solution is to fixate the mesh, but the question is, where do you tack it down with so many important structures?" 1 2 6 • O U T PA T I E N T S U R G E R Y M A G A Z I N E • M A Y 2 0 1 6 Open ventral hernia repair is one of the most common surgeries in the United States, but it has infection rates as high as 40%, says Lisa Jennings, PhD, professor of medicine at the University of Tennessee Health Science Center and chief scientific officer of Ariste Medical. To combat this common complication, Dr. Jennings and col- leagues from the university are developing a drug-eluting mesh designed to fight infection from the inside out. Ariste Medical's polypropylene mesh features a unique coating of antibiotics that keeps microbes at bay as the patient recovers. While the mesh isn't yet available — they hope to earn FDA approval early next year — studies have shown that it's successful at pre- venting bacteria from contaminating the surgical site immediately after surgery. In a study pre- sented at the Annual Hernia Repair Meeting of the American Hernia Society, researchers found that the mesh sustained antimicrobial activity against common bacteria for at least 14 days after implantation, as well as protection against a broad spectrum of bacterial pathogens associated with SSIs, such as MRSA and E. coli. "What's unique is that we are able to show robust antimicrobial activity for at least 14 days," says Dr. Jennings, noting that though there are other drug-eluting meshes on the market, those tend to remain antimicrobial for only 7 days. "We hope that in the long term, this would reduce the incidence of infection and have a positive impact on patient outcomes." — Kendal Gapinski • SSI PREVENTION Lisa Jennings, PhD, is developing a drug-eluting hernia mesh that helps prevent bacterial growth. FIGHT INFECTIONS Could Drug-Eluting Mesh Prevent SSIs?

Articles in this issue

Archives of this issue

view archives of Outpatient Surgery Magazine - Creative Ways to Save Money in the OR - May 2016 - Subscribe to Outpatient Surgery Magazine